Atlas Trials

Cancer of Unknown Primary Site

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Cancer of Unknown Primary Site

RecordFirmDate
FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary (NCT05263700)Peter MacCallum Cancer Centre, Australia2022-02-23
Sintilimab in Cancer of Unknown Primary (NCT05024968)M.D. Anderson Cancer Center2021-08-26
Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in China (NCT04952103)Fudan University2021-06-18
Carcinoma of Unknown Primary (CUP): a Comparison Across Tissue and Liquid Biomarkers (NCT04750109)The Christie NHS Foundation Trust2021-06-09
TCF-001 TRACK (Target Rare Cancer Knowledge) Study (NCT04504604)TargetCancer Foundation2020-10-01
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers (NCT04459273)Jonsson Comprehensive Cancer Center2020-08-27
Nivolumab/Ipilimumab in Second Line CUP-syndrome (NCT04131621)University Hospital Heidelberg2019-12-12
Trial of Pembrolizumab in Cancer of Unknown Primary (NCT03752333)Imperial College London2019-02-22
Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary (NCT03278600)Fudan University2017-09-18
APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors (NCT03053466)Apollomics (Australia) Pty. Ltd.2017-03-27
Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine (NCT01845337)University of Edinburgh2014-02-05

Track Cancer of Unknown Primary Site automatically

Every clearance here is in the API, with alerts when new ones post.